Therese Cronin

Title: Therese Cronin: Innovator in Age-Related Macular Degeneration Treatment

Introduction

Therese Cronin is a prominent inventor based in Paris, France. She has made significant contributions to the field of ophthalmology, particularly in the treatment of age-related macular degeneration (AMD). Her innovative work has the potential to improve the quality of life for many individuals affected by this condition.

Latest Patents

Therese Cronin holds a patent for "Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD)." This invention focuses on the use of RdCVFL polypeptide or polynucleotide in the treatment of AMD. The patent highlights the importance of her research in developing effective therapies for this debilitating eye disease.

Career Highlights

Throughout her career, Therese has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her dedication to research and innovation has positioned her as a leader in her field.

Collaborations

Therese has collaborated with notable colleagues, including Thierry Leveillard and Jose-Alain Sahel. These partnerships have furthered her research and contributed to advancements in the treatment of AMD.

Conclusion

Therese Cronin's work in the field of age-related macular degeneration exemplifies the impact of innovative research on healthcare. Her contributions continue to pave the way for new treatments and improved patient outcomes.